As an indispensable energy source, ammonia plays an essential role in agriculture and various industries. Given that the current ammonia production is still dominated by the energy-intensive and high carbon...
Photocatalytic conversion of carbon dioxide (CO2) into value‐added fuels is a vastly promising anthropogenic chemical carbon cycle to combat the greenhouse effect while meeting the ever‐increasing energy demand. Recently, lead‐based halide perovskites have demonstrated great potential in various applications including photochemical reduction of CO2. However, in view of lead toxicity, the exploration of a lead‐free alternative is crucial for long term application. Herein, a series of lead‐free mixed halide perovskites Cs3Sb2ClxBr9−x (0 ≤ x ≤ 9) is prepared via a facile antisolvent recrystallization technique, where the incorporation of a secondary halide enhances the charge transfer and separation while allowing precise tuning of bandgap between 2.59 and 2.90 eV. Theoretical calculations further reveal that the formation of mixed Cl/Br halides engenders favorable charge redistribution due to lower octahedral distortion, which in turn strengthens CO2 adsorption and activation. Under visible light illumination, the optimal dual halide perovskite, Cs3Sb2Cl4Br5 manifests substantial twofold and fourfold enhancements of CH4 yield over the single halide perovskite, Cs3Sb2Br9 and Cs3Sb2Cl9, respectively. In brief, this study provides a compelling demonstration of lead‐free mixed halide perovskites for photocatalytic CO2 reduction, and it is anticipated to drive further application of perovskite‐based photocatalysts toward a diverse range of artificial photoredox reactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.